Contrast media and enzyme inhibition. I. Cholinesterase
- 1 September 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 56 (669), 653-656
- https://doi.org/10.1259/0007-1285-56-669-653
Abstract
Cholinergic mechanisms, activated by the inhibition of the acetylcholine hydrolyzing enzyme cholinesterase, may be responsible for many of the adverse effects [in mice] of intravascular radiological contrast media [sodium iothalamate iohexol, iopamidol and sodium meglumine ioxaglate]. The relative cholinesterase-inhibiting activities of several conventional and new contrast media were measured and significant differences found. Some of the possible implications of these differences are discussed.This publication has 25 references indexed in Scilit:
- The new low-osmolar contrast media: A simple guideClinical Radiology, 1983
- A comparison of iopamidol and diatrizoate in peripheral angiographyThe British Journal of Radiology, 1982
- Release of Serotonin from Human Platelets In Vitro by Radiographic Contrast MediaInvestigative Radiology, 1981
- Cardiac Alterations During Intravenous UrographyInvestigative Radiology, 1980
- Ioxaglate, a new low osmolar contrast medium used in femoral angiographyThe British Journal of Radiology, 1979
- Adverse Reactions to Contrast Agents Scope of ProblemInvestigative Radiology, 1970
- Contrast Media as Histamine LiberatorsInvestigative Radiology, 1970
- Binding of Roentgenographic Contrast Media to Serum AlbuminInvestigative Radiology, 1967
- Inhibition of Acetylcholinesterase by Some Organic Contrast MediaInvestigative Radiology, 1966
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961